Who We Are
Pandu Biosains is an Indonesian-based distributor company for biotechnology and molecular biology research needs that has been supporting genomics programs in Indonesia since 2011. As a leading provider of Next-Generation Sequencing (NGS) and micro array technologies, we strive to support advancing genomic research and applications across the country. With the vision to be the leader in providing molecular biology tools and services, Pandu Biosains is committed to driving innovation and excellence in the field of genomics.
Human
Non-human
Instruments
Meet Pandu Biosains: Indonesia’s Leading Provider of NGS and Microarray Solutions
Our market leading NGS platform Illumina has been contributing to many of world’s genomics research to help improve health.
WHAT’S NEW
![Mengeksplorasi Variants of Uncertain Significance (VUS) melalui Pendekatan Sitogenetika](https://biosains.com/wp-content/uploads/2024/07/Market-Update.png)
Mengeksplorasi Variants of Uncertain Significance (VUS) melalui Pendekatan Sitogenetika
Kawan Biosains, salah satu tantangan terbesar dalam pengujian genetik saat ini adalah banyaknya variasi yang artinya belum diketahui (VUS). Variants of Uncertain…
![WHO mengonfirmasi kasus fatal pertama infeksi virus influenza A(H5N2) pada manusia](https://biosains.com/wp-content/uploads/2024/06/Untitled-design-13-edited.png)
WHO mengonfirmasi kasus fatal pertama infeksi virus influenza A(H5N2) pada manusia
Kawan Biosains, pada tanggal 23 Mei 2024, Mexico International Health Regulations (IHR) dan National Focal Point (NFP) melaporkan kepada WHO terkait infeksi…
![Event Recap: Siloam Oncology Summit 2024](https://biosains.com/wp-content/uploads/2024/05/WhatsApp-Image-2024-05-24-at-12.44.21-edited.jpeg)
Event Recap: Siloam Oncology Summit 2024
Pada tanggal 24-25 Mei yang lalu, Pandu Biosains berkesempatan hadir di Siloam Oncology Summit 2024 yang diadakan oleh MRCCC Siloam di JW…
Our Clients
Keep up with us!
Subscribe to our mailing list and be the first to get updates on upcoming events, our products and quarterly newsletter!